2025
SJR Q2
JCR Q3 · 2,4
OA
1 matched articles
ESCI
Journal detail
FASEB BioAdvances
- Publisher
- John Wiley and Sons Inc
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
25739832
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,776
- Quartile Q2
- H-Index 26
- Cites/doc 2,31
- Docs (3y) 145
- Cites (3y) 359
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,4
- 5Y JIF 2,9
- JCI 0,37
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Biochemistry, Genetics and Molecular Biology (miscellaneous) Q2
- Cancer Research Q3
- Molecular Medicine Q2
- Physiology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
WoS categories
- Biochemistry & Molecular Biology | Cell Biology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,776 | 2,4 | 2,9 | 0,37 | Q4 | 26 |
| 2024 | Q2 | Q4 | 0,748 | 2 | 2,4 | 0,39 | Q4 | 23 |
| 2023 | Q2 | Q3 | 0,764 | 2,5 | 2,6 | 0,39 | Q4 | 23 |
| 2022 | Q2 | — | 0,731 | 2,7 | 2,7 | 0,4 | Q4 | 23 |
| 2021 | Q2 | — | 0,713 | — | — | 0,37 | Q4 | 23 |
| 2020 | — | — | — | — | — | — | — | 23 |
| 2019 | — | — | — | — | — | — | — | 23 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | Q3 | Q4 | 244/328 |
| 2025 | CELL BIOLOGY | ESCI | Q4 | Q4 | 161/207 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | Q4 | Q4 | 255/320 |
| 2024 | CELL BIOLOGY | ESCI | Q4 | Q4 | 168/204 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | Q3 | Q4 | 216/313 |
| 2023 | CELL BIOLOGY | ESCI | Q3 | Q4 | 148/205 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | — | Q4 | — |
| 2022 | CELL BIOLOGY | ESCI | — | Q4 | — |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | — | Q4 | — |
| 2021 | CELL BIOLOGY | ESCI | — | Q4 | — |